Evidence map›Paper›PMID 35347324›Full record

ArticleBritish journal of cancer2022

PGC-1α induced mitochondrial biogenesis in stromal cells underpins mitochondrial transfer to melanoma.

Prakrit R Kumar, Mona Saad, Charlotte Hellmich, Jayna J Mistry, Jamie A Moore, Shannon Conway, Christopher J Morris, Kristian M Bowles, Marc D Moncrieff, Stuart A Rushworth

Open access · hybridAbstract read
In one paragraph

Article in British journal of cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Mitochondrial transfer in the HSC-HCC-macrophage network shapes hepatocellular carcinoma progression.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Mitochondrial bioenergetics and networks in melanoma: an update.Apoptosis : an international journal on programmed cell death · 2025
    Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Mitochondrial transfer in tunneling nanotubes-a new target for cancer therapy.Journal of experimental & clinical cancer research : CR · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Prakrit R KumarNorwich Medical School, University of East Anglia, Norwich Research Park, Norwich, NR4 7UQ, UK.
Mona SaadNorwich Medical School, University of East Anglia, Norwich Research Park, Norwich, NR4 7UQ, UK.
Charlotte HellmichNorwich Medical School, University of East Anglia, Norwich Research Park, Norwich, NR4 7UQ, UK.
Jayna J MistryNorwich Medical School, University of East Anglia, Norwich Research Park, Norwich, NR4 7UQ, UK.
Jamie A MooreNorwich Medical School, University of East Anglia, Norwich Research Park, Norwich, NR4 7UQ, UK.
Shannon ConwaySchool of Pharmacy, University of East Anglia, Norwich Research Park, Norwich, NR4 7TJ, UK.
Christopher J MorrisSchool of Pharmacy, University of East Anglia, Norwich Research Park, Norwich, NR4 7TJ, UK.
Kristian M BowlesNorwich Medical School, University of East Anglia, Norwich Research Park, Norwich, NR4 7UQ, UK.
Marc D MoncrieffNorwich Medical School, University of East Anglia, Norwich Research Park, Norwich, NR4 7UQ, UK. marc.moncrieff@nnuh.nhs.uk.ORCID http://orcid.org/0000-0003-4492-235X
Stuart A RushworthNorwich Medical School, University of East Anglia, Norwich Research Park, Norwich, NR4 7UQ, UK. s.rushworth@uea.ac.uk.ORCID http://orcid.org/0000-0002-3711-7558
University of East Anglia · GB

Funding

Medical Research Council MR/T02934X/1Wellcome Trust
6 · The paper itself

Abstract

introductionProgress in the knowledge of metabolic interactions between cancer and its microenvironment is ongoing and may lead to novel therapeutic approaches. Until recently, melanoma was considered a glycolytic tumour due to mutations in mitochondrial-DNA, however, these malignant cells can regain OXPHOS capacity via the transfer of mitochondrial-DNA, a process that supports their proliferation in-vitro and in-vivo. Here we study how melanoma cells acquire mitochondria and how this process is facilitated from the tumour microenvironment.

methodsPrimary melanoma cells, and MSCs derived from patients were obtained. Genes' expression and DNA quantification was analysed using Real-time PCR. MSC migration, melanoma proliferation and tumour volume, in a xenograft subcutaneous mouse model, were monitored through bioluminescent live animal imaging.

resultsHuman melanoma cells attract bone marrow-derived stromal cells (MSCs) to the primary tumour site where they stimulate mitochondrial biogenesis in the MSCs through upregulation of PGC1a. Mitochondria are transferred to the melanoma cells via direct contact with the MSCs. Moreover, inhibition of MSC-derived PGC1a was able to prevent mitochondrial transfer and improve NSG melanoma mouse tumour burden.

conclusionMSC mitochondrial biogenesis stimulated by melanoma cells is prerequisite for mitochondrial transfer and subsequent tumour growth, where targeting this pathway may provide an effective novel therapeutic approach in melanoma.

Indexed as

MelanomaMesenchymal Stem CellsAnimalsDNA, MitochondrialHumansMiceMitochondriaOrganelle BiogenesisTumor MicroenvironmentDNA, Mitochondrial

Identifiers

PMID35347324
PMCPMC9276678
OpenAlexW4220836957

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.